Approved Pathway for Biosimilars Must Be Patient-Focused
Eva M. Clayton
|
Posted 08.25.2012
|
Healthy Living
Read More:
Biosimilars,
Patients,
Health Care Costs,
Patient Safety,
Pharmaceuticals,
Health Care,
Biologics,
Healthy Living Health News,
Biosimilars Market,
Biosimilars Europe,
FDA Biosimilars,
Healthy Living News
The U.S. pharmaceutical industry has worked hard to become an international leader in the production of biotech drugs. But as the nation introduces these medicines, we need to ensure that safety protocols are in place -- so that every patient has the opportunity to get healthy.
